Kawanishi, Japan

Shigetoshi Tsubotani


Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 26(Granted Patents)


Location History:

  • Suita, JP (1985 - 1988)
  • Hyogo, JP (1990)
  • Kawanishi, JP (1994 - 1996)
  • Ibaraki, JP (1997)
  • Osaka, JP (2002)

Company Filing History:


Years Active: 1985-2002

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Shigetoshi Tsubotani: Innovator in Pharmaceutical Chemistry

Introduction

Shigetoshi Tsubotani is a prominent inventor based in Kawanishi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 8 patents to his name, Tsubotani's work has had a notable impact on medical science.

Latest Patents

Among his latest patents are innovative discoveries such as polyol-amino acid compounds that exhibit anti-helicobacter pylori activity. Additionally, he has developed epoxysuccinic acid derivatives, which have potential applications in various industries. These patents reflect his commitment to advancing pharmaceutical research and improving health outcomes.

Career Highlights

Tsubotani is currently employed at Takeda Chemical Industries, Inc., a leading global pharmaceutical company. His role at Takeda has allowed him to collaborate with other experts in the field and contribute to groundbreaking research initiatives. His work is characterized by a focus on creating effective solutions for complex health issues.

Collaborations

Throughout his career, Tsubotani has worked alongside notable colleagues, including Setsuo Harada and Masayuki Takizawa. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of various pharmaceutical products.

Conclusion

Shigetoshi Tsubotani's contributions to pharmaceutical chemistry are significant and impactful. His innovative patents and collaborations highlight his dedication to advancing medical science. Tsubotani continues to be a key figure in the field, driving forward the boundaries of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…